H igher blood pressure (BP) levels and variability seem to enhance vascular damage or lead to periods of organ hypoperfusion. [1] [2] [3] [4] [5] [6] Chronically higher BP is linked to lower cognitive function in individuals <50 years of age. [7] [8] [9] In addition to BP levels, our previous study revealed that BP variability during multiple time points (ie, long-term visit-to-visit BP variability) in young adulthood may be associated with lower cognitive function, and memory function in particular, at middle age. 10 However, whether visit-to-visit BP variability in young adulthood is associated with brain structural and functional changes is unknown.
Reductions in hippocampal volume and microstructural integrity are of particular interest because they are correlated with cognitive dysfunction, [11] [12] [13] [14] Alzheimer disease, 15, 16 and vascular dementia. 17 Sabayan et al, evaluated several brain magnetic resonance imaging (MRI) measures in relation to visit-to-visit BP variability in adults >70 years of age. These investigators observed that greater visit-to-visit BP variability was associated with lower hippocampal volumes. 18 Given that hippocampal neurons are highly vulnerable to disturbances of the cerebral circulation, 18, 19 we hypothesized that higher visitto-visit BP variability may be linked to lower hippocampal Abstract-The aims of this study are to assess the relationships of visit-to-visit blood pressure (BP) variability in young adulthood to hippocampal volume and integrity at middle age. We used data over 8 examinations spanning 25 years collected in the CARDIA study (Coronary Artery Risk Development in Young Adults) of black and white adults (age, 18-30 years) started in 1985 to 1986. Visit-to-visit BP variability was defined as by SD BP and average real variability (ARV BP , defined as the absolute differences of BP between successive BP measurements). Hippocampal tissue volume standardized by intracranial volume (%) and integrity assessed by fractional anisotropy were measured by 3-Tesla magnetic resonance imaging at the year-25 examination (n=545; mean age, 51 years; 54% women and 34% African Americans). Mean systolic BP (SBP)/diastolic BP levels were 110/69 mm Hg at year 0 (baseline), 117/73 mm Hg at year 25, and ARV SBP and SD SBP were 7.7 and 7.9 mm Hg, respectively. In multivariable-adjusted linear models, higher ARV SBP To understand the association of BP during young adulthood with brain structural changes at middle age, a lifespan approach is crucial. However, conducting lifespan studies is challenging because of the many years of follow-up required. We are uniquely positioned to fill these knowledge gaps, using data from the CARDIA study (Coronary Artery Risk Development in Young Adults). CARDIA enrolled black and white adults in young adulthood and followed them for 25 years via 8 clinical examinations. As a part of the year-25 examination, brain MRI scans were obtained in 710 participants. Using data from CARDIA, we sought to assess the relationships between visit-to-visit BP variability in young adulthood and hippocampal volume and integrity at middle age and to determine whether these associations are independent of cumulative exposure to BP levels in young adulthood.
Methods
The CARDIA study began in 1985 to 1986 with the examination of 5115 black and white adults aged 18 to 30 years from 4 US field centers: Birmingham, AL; Chicago, IL; Minneapolis, MN; and Oakland, CA. 20 All participants provided written informed consent, and institutional review boards at each field center and the coordinating center approved the study annually. By design, the cohort was balanced with respect to race (52% of the participants are black), sex (55% are women), and educational level (40% have ≤12 years of education). 25 , 72% of the surviving cohort was re-examined, and as part of this, a subsample was invited to participate in the CARDIA brain MRI substudy. 21 Participants for this substudy were recruited from 3 of the 4 CARDIA field centers (Birmingham, Minneapolis, and Oakland). Exclusion criteria at the time of sample selection, or at the MRI site, were a contraindication to MRI, suspected pregnancy, or a body size that was too large for the MRI tube bore. Separate written consent for participation in the brain MRI substudy was obtained, and separate approval was given by the institutional review boards governing participating sites. Of a total of 719 participants, 710 participants provided adequate MRI images for analysis.
BP and Other Measurements
Participants were asked to fast and to abstain from smoking or heavy physical activity for at least 12 hours before each examination. From the Y 0 to Y 15 examinations, trained research staff measured right-arm brachial artery BP 3× at 1-minute intervals after the participant had been sitting in a quiet room for 5 minutes, using a Hawksley randomzero sphygmomanometer (Hawksley, Sussex, United Kingdom). 10 The average of the second and third measurements was used for the analysis. At the Y 20 and Y 25 examinations, concerns about mercury contained in the apparatus required a switch to an automated oscillometric BP monitor (Omron HEM-907XL; Online Fitness, Santa Monica, CA). A calibration study was performed, and values standardized to the sphygmomanometric measures were used for Y 20 and Y 25 BP measurements, so that no machine bias remained. 10 The details are described in the online-only Data Supplement. Hypertension was defined as systolic BP (SBP) ≥140 mm Hg, diastolic BP (DBP) ≥90 mm Hg, or use of antihypertensive medication.
The primary exposure of the current study is visit-to-visit BP variability calculated from Y 0 to Y 25 BP measurements. We calculated the SD (SD BP : SD SBP and SD DBP ), coefficient of variation, the maximum and minimum BP difference, and average real variability (ARV BP : ARV SBP and ARV DBP ) across 8 visits (Figure) . ARV was calculated as (ΔBP1+ΔBP2+ΔBP3+ΔBP4+ΔBP5+ΔBP6+ΔBP7)/7 where ΔBP is the absolute difference between successive BP measurements. These measures have been used to describe visit-to-visit BP variability in previous studies. [1] [2] [3] [4] [5] [6] 10, 22 However, these parameters are partially dependent on the overall BP level and change in mean BP levels over time. Distinguishing BP variability from systemic changes in BP level over time (ie, slope) could thus be difficult. 4 The issue may not be resolved even if we use mean BP level over visits as an adjustment factor. Cumulative exposure to BP (mm Hg×years), defined as the summed average BP for each pair of consecutive examinations multiplied by the time between these 2 consecutive visits in years ( Figure) , 10 reflects not only mean BP level but also systemic change in BP level over time. 23 Therefore, we used cumulative exposure to BP as an adjustment factor.
Other data, including education, height, weight, smoking, alcohol consumption, physical activity, medication use, clinical history of cardiovascular disease, and fasting laboratory values, were collected using standardized protocols and quality control procedures across study centers. 20, 24 APOE phenotype was determined from plasma samples by a modification of the methods of Kamboh et al. 25 Participants were classified according to APOE phenotype (E2.2, E3.2, E3.3, E4.2, E4.3, and E4.4).
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MRI Acquisition and Processing
MRI scans were obtained for participants using 3-Tesla MR scanners located proximal to each CARDIA clinical site. Details of the scanners, training of MRI technologists at the different sites, implementation of study protocols, and quality assurance of scanner stability and performance are described in the online-only Data Supplement. 21 Normal tissue volumes of hippocampus, gray matter, white matter, and total brain (sum of the gray and white matter) and total intracranial volume (total brain plus cerebral spinal fluid volumes) were estimated from sagittal 3D T1 images. Each brain normal tissue volume was standardized by dividing each by the intracranial volume. Brain microstructural tissue integrity and organization were estimated from axial diffusion tensor images. Here, we analyzed the values of the diffusion tensor image-derived fractional anisotropy (FA). FA ranges from 0 to 1 and estimates the degree (or uniformity) to which water diffuses along the direction of myelinated tracks in the brain; a zero indicates equal probability of diffusion in all directions (ie, there is no Maximum and minimum SBP difference will be calculated as maximum SBP minus minimum SBP from Y 0 to Y 25 . Mean BP and SD over time will be calculated from 8 SBP measurements (Y 0 -Y 25 ) for each individual, and coefficient of variation will be calculated as SD/mean SBP over time. The average SBP between successive BP measurements is shown as A1 to A7. Cumulative exposure to SBP will be calculated as A1×2 y+A2×3 y+A3×2 y+A4×3 y+A5×5 y+A6×5 y+A7×5 y and is shown by the dotted area, representing in mm Hg×y. structural restriction to the flow of molecules), and a 1 indicates the diffusion occurs along one axis (eg, the white-matter tract). 21, 27 The clinical relevance of hippocampal FA as a measure of hippocampal integrity has been reported. 28, 29 Image processing was performed by the Section of Biomedical Image Analysis, Department of Radiology, University of Pennsylvania. The quality control procedures were described in the online-only Data Supplement. The technical error of measurementan accuracy index that reflects measurement quality of both acquisition and processing of scans-was estimated from scans of 3 people measured 3× in the 3 centers; results were 1.2% for total brain tissue volume and 3.4% for white-matter FA.
Statistical Analyses
Descriptive statistics are presented as means and SD, proportions, and medians with interquartile ranges where appropriate. Correlations between visit-to-visit BP variability measurements and clinical characteristics were calculated by Pearson correlation method. Multivariable-adjusted linear regression models were used to assess the association between visit-to-visit BP variability measurements and brain MRI variables (all as continuous variables). The primary outcomes were measures of hippocampal normal tissue volume and integrity (ie, [hippocampus volume×100]/ intracranial volume and hippocampal FA). The primary exposures were measures of visit-to-visit BP variability (ie, SD SBP , SD DBP , ARV SBP , and ARV DBP ). To determine whether associations were driven by total brain tissue, we also examined as secondary outcomes, associations of BP variability to total brain, gray matter, and white matter.
FA measures were log transformed before analyses because of the skewed distributions. Possible violations of the assumptions of multiple linear regression were examined by visual inspection of the distribution of residuals through both histograms and normal probability plots. We further checked for deviations of linearity and homoscedasticity by visually inspecting scatterplots of standardized residuals by standardized predicted values. In addition, we assessed variance inflation factors to examine the possibility of multicollinearity, and values >2.5 were considered to indicate collinearity. Covariates included demographic variables: age, sex, race, education attainment, and clinical characteristics at Y 25 : body mass index, smoking, physical activity, fasting glucose, and use of antihypertensive medications. These covariates were selected a priori because they have known correlations with BP variability [1] [2] [3] [4] [5] [6] 10, 22, 30 and brain structural abnormalities 31 and could potentially confound the association between these 2 variables. Analyses for heterogeneity of effect between visit-to-visit BP variability measurements and brain MRI variables by sex or race were performed, with inclusion of additive interaction terms.
We conducted sensitivity analyses by (1) excluding individuals taking antihypertensive medications during follow-up; (2) defining BP measurements through Y 0 to Y 20 , avoiding the inclusion of the late assessment of BP (Y 25 ) that might already have been affected by comorbidities (eg, atherosclerotic and brain function changes); 1, 2 and (3) imputing missing data on BP and covariates. We used multiple imputation chained equations with 20 iterations as described by Raghunathan et al. 32 All statistical analyses were performed with STATA, version 12.1 (STATACorp, College Station, TX). Statistical significance was defined by a P value <0.05 using 2-sided tests.
Results
Of the 710 participants, we excluded 5 participants who experienced stroke before the Y 25 examination, 132 participants with at least 1 missing BP measurement during the followup period, and 26 participants with any missing covariates at Y 25 , leaving a sample of 547 participants for analysis. Of the 547 participants, 54% were women, 34% were black race, mean (SD) age at baseline was 26 (3) years, and 22% reported antihypertensive medication use during follow-up ( Table 1 ).
The race-or sex-specific prevalence of hypertension at Y 25 was black individuals, 38.0%; white individuals, 20%; men, 26.2%; and women, 26.1%. The coefficient of variation and the maximum and minimum BP differences were strongly correlated with SD BP (Pearson r, >0.95; Table S1 in the onlineonly Data Supplement), and, therefore, we only report SD BP and ARV BP as a measure of BP variability. ARV SBP and SD SBP were positively associated with cumulative exposure to SBP (Pearson r, 0.2-0.4) . Tables S2 through S4 show the associations of ARV BP and SD BP with clinical characteristics. ARV SBP and SD SBP were higher , whereas cumulative exposure to SBP was lower in women than in men. Black race, higher body mass index, smoking, and antihypertensive medication use during followup were associated with higher ARV SBP and SD SBP (P<0.05 for all). Apolipoprotein E ε4 allele was not associated with ARV BP and SD BP .
With adjustments for covariates, including cumulative exposure to SBP, higher ARV SBP was associated with lower normal tissue volumes of the hippocampus, gray matter, and total brain, whereas higher ARV DBP and SD DBP were associated with lower white matter and total brain volumes ( Table 2 ). In model 1A or 2A in Table 2 Higher SD SBP was associated with lower value of hippocampal FA, independent of cumulative exposure to SBP (Table 3 , model 1B). Additional adjustments by apolipoprotein E ε4 allele (0 versus ≥1), pulse pressure at Y 25 , drinking status at Y 25 , and total cholesterol and high-density lipoprotein cholesterol levels at Y 25 did not change the results (data not shown).
There was no evidence of interaction between ARV BP (or SD BP ) and sex or race in association with brain MRI variables (all P>0.15). Results were similar when participants taking antihypertensive medications were excluded (analytic sample n=425; Tables S5 and S6 Results were generally similar when BP variability measurements based on these 7 visits were used as the exposure (data not shown). We imputed missing BP measurements and covariates, giving a sample of 710 participants for analysis. The observation numbers of imputed BP and covariates are shown in Table S7 . In 710 participants, the estimated mean (SD) age at baseline was 25 (4) years, 53% were women, 40% were blacks, and 24% had antihypertensive medication use at Y 15 . Mean values of ARV BP and SD BP using imputation were similar to those without imputation (Table S8) . Results with and without imputing missing BP and covariates were similar in terms of the point estimate for ARV BP and SD BP (Tables S9 and S10 ).
Discussion
In this community-based biracial cohort of young adults followed for 25 years, higher ARV SBP in young adulthood was associated with lower normal tissue volumes of the hippocampus, gray matter, and total brain. In contrast, higher ARV DBP was associated with lower white-matter normal tissue volume. We also found higher SD SBP in young adulthood to be associated with lower hippocampal integrity at middle age. These associations were independent of cumulative exposure to SBP over time. No heterogeneity of effect between visit-to-visit BP variability measurements and hippocampus volume and integrity measures by sex or race was observed.
Associations between visit-to-visit BP variability measurements and brain volume and integrity measures have been described but only in middle-aged and older adults. 19, 33, 34 In the Honolulu-Asia aging study that recruited 575 JapaneseAmerican men, higher visit-to-visit SBP variability in midlife (45-70 years old) was associated with white-matter hyperintensities and brain ventricular atrophy in their eighties. 33 In the PROSPER study (Prospective Study of Pravastatin in the Elderly at Risk), higher visit-to-visit SBP variability at an old age (>70 years) was associated with lower hippocampal volume (7.6 cm 2 in the 1st tertile versus 7.5 cm 2 in the 2nd tertile versus 7.4 cm 2 in the 3rd tertile of BP variability: P for trend=0.01). 18 However, BP variability in middle-aged and older populations might be affected by comorbidities (eg, [silent] brain abnormalities and atherosclerosis). The design of our study, recruiting young adults without known stroke, minimized these potential confounding issues.
Cross-sectional observations from the Framingham Heart Study illustrated that among 579 white young and middleaged adults (19-63 years old), higher SBP levels were linearly associated with lower gray-matter volume and white-matter integrity (assessed by FA). 35 Hippocampal volume and integrity were not assessed. In addition, BP was measured on a single occasion 35 -a snapshot of BP that may not fully characterize an individual's BP phenotypes in young adulthood that are linked to brain structural abnormalities later in life. We extend the finding by demonstrating that in a biracial cohort, those with higher visit-to-visit SBP variability instead of cumulative exposure to SBP in young adulthood were more likely to have lower hippocampal volume and integrity in middle age. 10 There are several potential mechanisms that may underlie the observed visit-to-visit SBP variability-hippocampus association. First, excess BP variability seems to enhance vascular damage and lead to periods of organ hypoperfusion. 1, 2 This may be true when short-term (eg, beat-to-beat) BP variability is high. In contrast, whether this phenomenon also happens when visit-to-visit BP variability is high remains unclear. This is because short-term and long-term BP variability are weakly correlated, and thus their pathophysiology may not be identical. 2, 22 Second, large-artery stiffness-a major contributor to visit-to-visit SBP variability increase 36 -may mediate relations between higher visit-to-visit SBP variability and hippocampal structural abnormalities. Large-artery stiffness was shown to correlate with brain structural abnormalities, 37 ,38 potentially through microvascular injury by exposing Data are expressed as the means±SD and percentages. ARV indicates average real variability; BP, blood pressure; DBP, diastolic blood pressure; FA, fractional anisotropy; ICV, intracranial volume; MRI, magnetic resonance imaging; NA, not applicable; and SBP, systolic blood pressure. *Brain normal tissue volume was standardized by dividing each by the intracranial volume.
†FA measures, shown as medians with interquartile ranges, was not obtained from all participants (n=540). the cerebrovasculature to high pressure fluctuations and flow pulsatility. 39, 40 To test this possibility, analyses were performed adjusting for pulse pressure, with similar results observed. However, pulse pressure is an indirect marker of large arterial stiffness. 41 Third, higher visit-to-visit SBP variability may be merely epiphenomena of other contributing conditions. For example, adverse stressors (eg, psychosocial stress and sleep deprivation), neurohormonal activation (eg, sympathetic nerve activation), lower socioeconomic status, or poor diet could lead to both visit-to-visit SBP variability increase and hippocampal damages. 1, 2, 42, 43 We observed that cumulative exposure to SBP or DBP was not associated with hippocampal volume. Mean±SD cumulative exposure to SBP and DBP during 25 years of follow-up was 2761.7±232.4 (110.4 mm Hg per year) and 1765.0±186.8 mm Hg×years (70.6 mm Hg per year), respectively. Furthermore, the prevalence of hypertension at Y 25 in this population seems to be lower than the prevalence in the US general population of the same age. 44 Although the reason is unclear, the difference might result from research participation effects (ie, the Hawthorne effect). 45 This effect might mitigate BP increases during follow-up in CARDIA participants, which potentially dilutes any true association between cumulative exposure to BP and brain outcomes.
ARV SBP was more consistently associated than SD SBP with normal tissue volumes of the hippocampus, gray matter, and total brain, whereas SD SBP but not ARV SBP was associated with hippocampal integrity. Despite the strong correlation between ARV SBP and SD SBP (Pearson r, 0.7), their clinical implication may not be identical. ARV BP weights for the between-reading time intervals and takes into account the order of the clinic visits at which BP was measured.
1,2 Conversely, SD BP is influenced by outliers or extreme BP values. 1, 2, 46 We also observed that higher ARV SBP was associated with lower gray-matter normal tissue volume, whereas higher ARV DBP with lower white-matter normal tissue volume. Different BP components reflect distinctive hemodynamics and pathophysiology.
47 DBP, at least ≤50 years of age, reflects a steady-state load of BP and is representative of resistant vessel structure and function alterations. 48, 49 In contrast, SBP is an integrated measure of steady and pulsatile pressure load and representative of large arterial (aortic) stiffness and cardiac output. 48, 50 To understand how hemodynamic physiology differs between gray and white matter and whether the effect of each BP metrics is in fact regionally specific will require further investigations.
Strengths of this study include the well characterized, community-based biracial cohort and the standardized data collection protocols and rigorous quality control of the CARDIA study. However, there are limitations. First, because this is an observational study, we are unable to determine the direction of the relationships observed. We cannot conclude whether BP-lowering therapies for young adults with greater visit-to-visit BP variability are useful to prevent or slow cognitive decline. Visit-to-visit BP variability has been shown to be associated with lifestyle factors, including diet, exercise, smoking, and sleep. 10, 22, 51, 52 Therefore, visit-to-visit BP variability measurements may be useful to identify young adults who may benefit from lifestyle modifications to maintain healthy brain function across their life spans. Second, we could not assess changes in hippocampal volume and integrity from baseline to follow-up, and thus, we cannot conclude whether low hippocampal volume or integrity at middle age reflects structural changes. Third, although statistically significant, the effect sizes of visit-to-visit SBP variability on hippocampal volume and integrity might be relatively small. Even subtle changes in hippocampal volume and integrity could result in a significant change in cognitive function, [14] [15] [16] [17] it is unknown whether lower hippocampal volume and integrity associated with greater visit-to-visit SBP variability are linked to clinical outcomes. We need data from future CARDIA examinations, including cognitive function measures, to explore longitudinal cognitive function in participants who had greater visit-to-visit BP variability. Fourth, we did not adjust for multiple testing. However, our analyses were not hypothesis free, that is, this study was executed based on our prior work that illustrated the associations of higher visit-to-visit SBP variability in young adulthood with lower verbal memory at middle age. 10 Most of the significant hippocampus-BP variability associations we found were indicated by P values <0.05. Therefore, our results should be interpreted cautiously. Lastly, our findings may not be generalizable to other racial/ethnic groups (eg, Asians).
Perspectives
We highlight the clinical relevance of visit-to-visit BP variability in young adulthood, that is, both BP levels overall, and BP variability specifically, seem important in identifying risk for brain structural abnormalities later in life. Validation of our findings in different studies/cohorts is warranted. Further studies will be required to determine whether reductions in visit-to-visit BP variability in young adulthood can help to limit declines in brain volume and integrity with aging.
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